With its latest expansion, ZS is placing a decisive bet on India’s role as the global engine room for life sciences. The firm is scaling talent, deepening its footprint and aligning to the next decade of pharma transformation that will increasingly be driven from India.
India’s pharmaceutical story is entering a breakout phase. What began with India becoming the “pharmacy of the world” is now transforming into something deeper — a high-value, innovation-led ecosystem powered by biotech upgrades, digital health capabilities and a fast-growing network of Global Capability Centres (GCCs).
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
